论文部分内容阅读
Objectives EVT,a strong antagonist to P2X7 receptor for non-steroidal anti-inflammatory was discovered through high-throughput screening.However,as a BCS II drug,EVT possesses poor and pH-independent aqueous solubility,hindering its further clinical application.